Mini ReviewThe role of Staphylococcus epidermidis in neonatal sepsis: Guarding angel or pathogenic devil?
Introduction
Advances in neonatal intensive care have dramatically reduced the mortality rate of premature infants during the last two decades [Sweet et al., 2013]. However, the increasing survival of preterm infants is complicated by a growing burden of short-term and long-term problems associated with nosocomial infections [Marchant et al., 2013]. The last two decades have seen coagulase-negative staphylococci (CONS), especially Staphylococcus epidermidis, emerge as the predominant pathogen responsible for neonatal late-onset sepsis mainly in industrialized countries [Bizzarro et al., 2005, Marchant et al., 2013]. S. epidermidis is permanently present in the nosocomial environment and can disseminate widely among hospitals in different regions, adding to the morbidity, mortality and medical cost [Strunk et al., 2007, Power Coombs et al., 2013]. The evolving paradigm of S. epidermidis sepsis is a significant change from the traditionally held view, which envisioned S. epidermidis as a harmless skin inhabitant. Interdisciplinary collaborations at the interface of microbiology and immunology have generated new insights into the nature of S. epidermidis, showing that S. epidermidis mostly engages itself in a beneficial way in host defense and immune maturation, but may adopt an infectious lifestyle under certain circumstances [Cogen et al., 2008, Otto, 2009]. A thorough and comprehensive understanding of how S. epidermidis successfully establishes itself as the most widespread pathogen in the nosocomial environment may help to expand our armamentarium of anti-infectious strategies.
Section snippets
Clinical aspects of S. epidermidis neonatal sepsis
Neonatal sepsis is one of the leading causes of neonatal death [Qazi and Stoll, 2009]. Early-onset sepsis (EOS), reflecting trans-placental, or more frequently, ascending infections from the maternal genital tract, occurs within 72 h of age [Behrman et al., 2004]. In contrast, late-onset sepsis (LOS) is associated with the postnatal healthcare environment and usually presents after 72 postnatal hours, with the peak incidence between the 15th and 17th day of life [Stoll et al., 2002, Hira et al.,
The beneficial function of S. epidermidis on neonates
S. epidermidis normally maintains a benign relationship with the host and primarily has not evolved to become a pathogen [Otto, 2009]. In contrast to the abundant information on the infectious role of S. epidermidis, our understanding of the beneficial role of S. epidermidis on neonates is considerably limited. S. epidermidis colonizes on the skin immediately after birth, and rapidly dominates the microflora of various body sites within the first month of life [Capone et al., 2011]. Although
S. epidermidis as a pathogen in neonatal sepsis
Nosocomial factors, such as the disruption of the skin barrier by medical devices and the selection pressure due to the widespread use of antibiotics, may drive the conversion of S. epidermidis from a mutualistic microbe toward a pathogen [Otto, 2009]. Epidemiological studies in the past decade showed that the dissemination of S. epidermidis in hospitals including neonatal wards was attributable to several clonal lineages [Kozitskaya et al., 2004, Hira et al., 2007, Klingenberg et al., 2007, Li
Neonatal immune response to S. epidermidis
It is widely believed that the susceptibility of neonates to nosocomial sepsis arises, at least in part, from an immature immunity, marked by deficiencies in numerous components of the immune system. However, this view is challenged by accumulating evidence which demonstrates that the neonatal immune system is not simply immature, but rather specifically regulated for the early postnatal life [Ghazal et al., 2013, Levy and Wynn, 2014]. A highly tolerant immune reaction, characterized by
Therapeutic prospect of neonatal sepsis caused by S. epidermidis
The dual role of S. epidermidis as both a beneficial symbiont and a potential pathogen, the dwindling arsenal of antibiotics to combat increasingly resistant bacteria and the particularities of the neonatal immune system are major factors contributing to the difficulties in treatment of S. epidermidis sepsis. Eradication of S. epidermidis from skin would be undesirable and even counterproductive, given the beneficial functions of S. epidermidis in defending against other pathogens and educating
Conclusion
As the predominant component of human skin microbiome, S. epidermidis contributes fundamentally to the well-being of neonates, and the immune system has evolved to tolerate S. epidermidis on the uppermost layer of body. However, several extrinsic factors associated with the nosocomial environment may disturb this delicate host-microbe balance, resulting in a lifestyle conversion of S. epidermidis from mutualism to pathogenicity. In other words, the very interventions used to treat premature
Acknowledgements
Dr Ying Dong received a scholarship under the State Scholarship Fund organized by the China Scholarship Council (CSC) (No. 201308500098).
References (96)
- et al.
Diversity of the human skin microbiome early in life
J. Invest. Dermatol.
(2011) - et al.
Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial
Lancet
(2009) - et al.
Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin
J. Invest. Dermatol.
(2010) - et al.
Surface protein adhesins of Staphylococcus aureus
Trends Microbiol.
(1998) - et al.
The emergence and evolution of methicillin-resistant Staphylococcus aureus
Trends Microbiol.
(2001) - et al.
Persistent strains of coagulase-negative staphylococci in a neonatal intensive care unit: virulence factors and invasiveness
Clin. Microbiol. Infect.
(2007) - et al.
Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections
J. Invest. Dermatol.
(2010) - et al.
Prevalence of resistance to antiseptics and mupirocin among invasive coagulase-negative staphylococci from very preterm neonates in NICU: the creeping threat?
J. Hosp. Infect.
(2013) - et al.
Mechanisms of biofilm resistance to antimicrobial agents
Trends Microbiol.
(2001) Phenol-soluble modulins
Int. J. Med. Microbiol.
(2014)
Success through diversity – how Staphylococcus epidermidis establishes as a nosocomial pathogen
Int. J. Med. Microbiol.
Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways
J. Invest. Dermatol.
An outbreak of methicillin resistant Staphylococcus epidermidis among neonates in a hospital in Saudi Arabia
J. Infect. Dev. Ctries.
Neonatal infections in China, Malaysia Hong Kong and Thailand
Arch. Dis. Child. Fetal Neonatal Ed.
Risk factors associated with development of persistent coagulase-negative staphylococci bacteremia in the neonate and associated short-term and discharge morbidities
Neonatology
Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo
Pediatr. Res.
Infections of the neonatal infant
Nelson Textbook of Pediatrics
Nosocomial sepsis in neonatal intensive care: inevitable or preventable?
Z. Geburtshilfe Neonatol.
Lantibiotics: mode of action, biosynthesis and bioengineering
Curr. Pharm. Biotechnol.
Seventy-five years of neonatal sepsis at Yale: 1928–2003
Pediatrics
Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births
J. Pediatr.
Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists
Int. J. Mol. Sci.
Characterisation and expression of fatty acid modifying enzyme produced by Staphylococcus epidermidis
J. Med. Microbiol.
Phenol-soluble modulins – critical determinants of staphylococcal virulence
FEMS Microbiol. Rev.
Staphylococcus epidermidis strategies to avoid killing by human neutrophils
PLoS Pathog.
Understanding of the significance of Staphylococcus epidermidis bacteremia in babies and children
Curr. Opin. Infect. Dis.
Skin microbiota: a source of disease or defence?
Br. J. Dermatol.
Bacterial biofilms: a common cause of persistent infections
Science
A systematic review and meta-analysis of long-term development of early term infants
Neonatology
Molecular cloning and biochemical characterisation of proteases from Staphylococcus epidermidis
Biol. Chem.
Early life response to infection
Curr. Opin. Infect. Dis.
Toll-like receptor signaling in neonatal sepsis and inflammation: a matter of orchestration and conditioning
Expert Rev. Clin. Immunol.
Topographical and temporal diversity of the human skin microbiome
Science
Incidence, aetiology and resistance of late-onset neonatal sepsis: a five-year prospective study
J. Paediatr. Child Health
Genetic association studies in VLBW infants exemplifying susceptibility to sepsis – recent findings and implications for future research
Acta Paediatr.
Features of invasive staphylococcal disease in neonates
Pediatrics
Clinical and molecular epidemiologic characteristics of coagulase-negative staphylococcal bloodstream infections in intensive care neonates
Pediatr. Infect. Dis. J.
Small bowel perforation in the premature neonate: congenital or acquired?
Pediatr. Surg. Int.
Mutation of tagO reveals an essential role for wall teichoic acids in Staphylococcus epidermidis biofilm development
Microbiology
Treatment of neonatal sepsis with intravenous immune globulin
N. Engl. J. Med.
A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units
Arch. Dis. Child. Fetal Neonatal Ed.
Staphylococcus epidermidis and Staphylococcus aureus trigger different interleukin-8 and intercellular adhesion molecule-1 in lung cells: implications for inflammatory complications following neonatal sepsis
Acta Paediatr.
Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization
Nature
Induction of inflammatory cytokines and nitric oxide in J774.2 cells and murine macrophages by lipoteichoic acid and related cell wall antigens from Staphylococcus epidermidis
J. Med. Microbiol.
Molecular detection of late-onset neonatal sepsis in premature infants using small blood volumes: proof-of-concept
Neonatology
Key role of poly-gamma-dl-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis
J. Clin. Invest.
The bacterial insertion sequence element IS256 occurs preferentially in nosocomial Staphylococcus epidermidis isolates: association with biofilmformation and resistance to aminoglycosides
Infect. Immun.
Clonal analysis of Staphylococcus epidermidis isolates carrying or lacking biofilm-mediating genes by multilocus sequence typing
J. Clin. Microbiol.
Cited by (0)
- 1
Present address: Children's Hospital of Fudan University, Shanghai, China.